Vistagen Therapeutics
VTGN · NASDAQ
$0.1978−$0.0053 (−2.61%)TodayMarket closed ·
Prev close $0.2031
Who owns VTGN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 22.1% of VTGN’s shares.
- Commodore Capital LP6.8%
- Vanguard Capital Management, LLC3.8%
- Two Sigma Investments, LP2.1%
- Acadian Asset Management LLC1.9%
- Next 6 largest institutions7.5%
- All other shareholders77.9%
| Holder | Shares | % of shares |
|---|---|---|
| Commodore Capital LP | 2.79M | 6.80% |
| Vanguard Capital Management, LLC | 1.57M | 3.84% |
| Two Sigma Investments, LP | 847.99K | 2.07% |
| Acadian Asset Management LLC | 794.58K | 1.94% |
| Renaissance Technologies LLC | 730.50K | 1.78% |
| StemPoint Capital LP | 616.75K | 1.50% |
| Ikarian Capital LLC | 519.08K | 1.27% |
| AdvisorShares Investments, LLC | 438.64K | 1.07% |
| Luminus Management, L.L.C. | 403.12K | 0.98% |
| Geode Capital Management, L.L.C. | 365.00K | 0.89% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.16M | 2.83% |
| Biotech Growth Trust PLC | 808.70K | 1.97% |
| AdvisorShares Psychedelics ETF | 525.15K | 1.28% |
| Vanguard Extended Market Index Fund | 413.75K | 1.01% |
| Fidelity Extended Market Index Fund | 189.56K | 0.46% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of VTGN in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Williamson Douglas J | Award | 40.83K | — |
| Adler Reid G. | Award | 36.82K | $7.07K |
| Tressler Nick B. | Award | 11.71K | $2.25K |
| Singh Shawn | Award | 36.82K | $7.07K |
| Angelov Angel S | Award | 150.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.75M
- Days to cover
- 1.00
- % of shares outstanding
- 9.14%
- Average daily volume
- 55.16M
- Change since last report
- +38.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.